<DOC>
	<DOC>NCT01104545</DOC>
	<brief_summary>This study will determine if MK3614, given as single doses, is safe and well tolerated in healthy males and male subjects with mild to moderate hypertension.</brief_summary>
	<brief_title>A Single Dose Study of MK3614</brief_title>
	<detailed_description />
	<criteria>Healthy subjects between 18 to 45 years of age; otherwise healthy subjects between 18 to 55 years of age newly diagnosed with grade 1 or 2 hypertension Subject is in good general health Subject is a nonsmoker Subject has a history of stroke, seizure or major neurological disease Subject has functional disability that can interfere with rising from a sitting position to a standing position Subject has a family history of a bleeding or clotting disorder Subject has a history of cancer Subject is unable to refrain from or anticipates the use of any prescription or nonprescription medication during the study Subject consumes excessive amounts of alcohol or caffeine Subject has had major surgery, donated blood or participated in another investigational study in the past 4 weeks.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>